AR and Familial prostate cancer: Recent studies have shown that AMPK activation suppresses AR levels and inhibits prostate cancer cell proliferation and tumor growth [32, 56, 57], and that this response is magnified in the presence of an AR antagonist [32, 57], similar to our observations with ACLY inhibition in this study.